Seven Eight Capital’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,580	Closed	-$181K	–	606
2022 Q4	$181K	Buy	+11,580	New	+$162K	0.05%	378
2022 Q3	–	Sell	-14,772	Closed	-$207K	–	624
2022 Q2	$207K	Buy	14,772 +922	+7%	+$13.2K	0.08%	337
2022 Q1	$198K	Sell	13,850 -8,169	-37%	-$120K	0.03%	492
2021 Q4	$300K	Sell	22,019 -105,856	-83%	-$1.48M	0.05%	360
2021 Q3	$2.1M	Buy	127,875 +46,200	+57%	+$776K	0.2%	177
2021 Q2	$1.38M	Buy	+81,675	New	+$1.39M	0.19%	179
2020 Q3	–	Sell	-17,820	Closed	-$320K	–	647
2020 Q2	$320K	Sell	17,820 -2,980	-14%	-$53.5K	0.23%	179
2020 Q1	$316K	Buy	20,800 +7,126	+52%	+$129K	0.08%	305
2019 Q4	$270K	Sell	13,674 -27,000	-66%	-$517K	0.01%	588
2019 Q3	$700K	Buy	40,674 +30,600	+304%	+$529K	0.04%	476
2019 Q2	$178K	Buy	+10,074	New	+$183K	0.01%	555